NEUROSENSE THERAPEUTICS LTD (NRSN) Stock Balance Sheet
USA - NASDAQ:NRSN - IL0011809592 - Common Stock
1.18 USD
+0.02 (+1.72%)
1.1307 USD
-0.05 (-4.18%)
| MRQ (2024-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 344.00K | N/A | 2.64M | 3.54M | 11.06M | |||
| Marketable Securities | N/A | N/A | 0.00 | 3.55M | N/A | |||
| Receivables | 406.00K | 900.00K | 170.00K | 130.00K | 180.00K | |||
| Other Current Assets | 35.00K | 130.00K | 110.00K | 160.00K | 170.00K | |||
| Total Current Assets | 785.00K | 4.40M | 2.92M | 7.38M | 11.41M | |||
| Non-Current Assets | ||||||||
| PPE Net | 176.00K | 150.00K | 250.00K | 310.00K | 20.00K | |||
| Other Non-Current Assets | 23.00K | N/A | 22.00K | 20.00K | N/A | |||
| Total Non-Current Assets | 199.00K | 180.00K | 270.00K | 330.00K | 20.00K | |||
| TOTAL ASSETS | 984.00K | 4.58M | 3.19M | 7.71M | 11.43M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 69.00K | 60.00K | N/A | |||
| Accrued Expenses | N/A | 830.00K | 2.00M | 1.16M | 560.00K | |||
| Accounts Payable | 1.39M | 1.16M | 1.46M | 500.00K | 40.00K | |||
| Other Current Liabilities | 2.39M | N/A | 2.00M | N/A | N/A | |||
| Total Current Liabilities | 3.78M | 1.99M | 3.46M | 1.73M | 600.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 19.00K | 0.00 | 0.00 | 150.00K | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 0.00 | 1.49M | 220.00K | 1.83M | |||
| Total Non-Current Liabilities | 19.00K | 0.00 | 1.48M | 360.00K | 1.83M | |||
| TOTAL LIABILITIES | 3.80M | 1.99M | 4.94M | 2.09M | 2.43M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -34.53M | -37.00M | -26.00M | -20.79M | -8.45M | |||
| Additional Paid In Capital | 31.71M | 39.00M | 24.00M | 26.41M | 17.45M | |||
| Common Shares | 0.00 | N/A | 0.00 | 0.00 | N/A | |||
| Shares Outstanding | 19.81M | 23.00M | 15.00M | 11.78M | 10.94M | |||
| Tangible Book Value per Share | -0.14 | N/A | -0.11 | 0.48 | 0.82 | |||
| Total Shareholders' Equity | -2.82M | 2.58M | -1.76M | 5.62M | 9.01M | |||
| TOTAL LIABILITIES AND EQUITY | 984.00K | 4.58M | 3.19M | 7.71M | 11.43M | |||
| Statistics | ||||||||
| Debt/Equity | -0.01 | N/A | N/A | 0.03 | N/A | |||
| Current Ratio | 0.21 | 2.21 | 0.84 | 4.27 | 19.02 | |||
| Return On Assets (ROA) | -1061.28% | -222.93% | -316.83% | -160.05% | -35.35% | |||
| Return On Equity (ROE) | N/A | -395.74% | N/A | -219.57% | -44.84% | |||
All data in USD , ROIC based on taxRate of 0.21